Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(10):801-802; doi:10.1093/jnci/djh149
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by O’Connell, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Connell, M.
Related Collections
Right arrowCorrespondence about this Article
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

PET–CT Modification of RECIST Guidelines

Martin O’Connell

Correspondence to: Martin O’Connell, MD, Divisions of Nuclear Medicine and Abdominal Imaging, Department of Radiology, Duke University Medical Center, DUMC Box 3949, Durham, NC 27710 (e-mail: martinoconnell@hotmail.com)

The first 10% of the full text of this article appears below.

The World Health Organization's 1981 criteria (1) for tumor size evaluation in response to cytotoxic treatment were simplified to the RECIST (Response Evaluation Criteria in Solid Tumors) guidelines (2) as a result of a consensus task force established in 1994. The purpose of this modification was to standardize measurements of lesion size in response to chemotherapy in adults (2,3). The RECIST guidelines were designed to allow accurate, reproducible measurements without . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

RESPONSE: Re: PET–CT Modification of RECIST Guidelines
Patrick Therasse
J Natl Cancer Inst 2004 96: 802. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 JCOHome page
N. Avril, S. Sassen, B. Schmalfeldt, J. Naehrig, S. Rutke, W. A. Weber, M. Werner, H. Graeff, M. Schwaiger, and W. Kuhn
Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
J. Clin. Oncol., October 20, 2005; 23(30): 7445 - 7453.
[Abstract] [Full Text] [PDF]